Derma Sciences Announces Multiple Clinical Posters Featuring MEDIHONEY(R) and ALGICELL Ag(R) to be Presented at Upcoming Wound Care ConferenceClinical evidence continues to build for the company's key technologies
PRINCETON, N.J., Oct. 22 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTCBulletinBoard: DSCI) , a company specializing in advanced wound care, today announced that eleven clinical posters focusing on its new technologies have been accepted and will be presented at next week's Clinical Symposium on Advances in Skin & Wound Care in Las Vegas.
The products featured include MEDIHONEY dressing with Active Leptospermum Honey…
Four of the most recently completed and not previously announced posters featuring Derma Sciences' products include:
"Limb at Risk: Use of Active Leptospermum Honey for the management of an infected foot wound complicated by cellulitis."…
"Active Leptospermum Honey: Treatment for various lower extremity dermatologic issues."…
"Management of an MRSA colonized wound using Active Leptospermum Honey impregnated calcium alginate."…
"A cost-effective alternative: Investigating absorbent gelling calcium alginate dressings with antimicrobial silver."…
No comments:
Post a Comment